Anti-Saccharomyces cerevisiae Antibodies Are Only Modestly More Common in Subjects Later Developing Crohn's Disease.
L Bodecker-ZingmarkL WidbomJ HultdinC ErikssonPontus KarlingPublished in: Digestive diseases and sciences (2022)
We found no significant increase in antibodies typical for IBD years before diagnosis except for ASCA, which was slightly more common in subjects who later developed CD. Very few subjects had detectable antibodies to goblet cells and pancreas antigen.